PIRAMAL PHARMA LIMITEDPIRAMAL PHARMA LIMITEDPIRAMAL PHARMA LIMITED

PIRAMAL PHARMA LIMITED

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪334.09 B‬INR
0.35INR
‪178.20 M‬INR
‪81.71 B‬INR
‪618.13 M‬
Beta (1Y)
−0.37
Employees (FY)
‪7.93 K‬
Change (1Y)
‪+1.01 K‬ +14.54%
Revenue / Employee (1Y)
‪10.30 M‬INR
Net income / Employee (1Y)
‪22.46 K‬INR

About PIRAMAL PHARMA LTD


CEO
Peter Daniel DeYoung
Headquarters
Mumbai
Founded
2020
ISIN
INE0DK501011
FIGI
BBG012W4NGS9
Piramal Pharma Ltd. engages in development and manufacturing of pharmaceutical products. It offers skin care, vitamins and nutrition, antacids, analgesics, gastro-intestinal, and baby-care. The company was founded on March 4, 20202 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PPLPHARMA is 249.25 INR — it has decreased by −1.09% in the past 24 hours. Watch PIRAMAL PHARMA LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange PIRAMAL PHARMA LIMITED stocks are traded under the ticker PPLPHARMA.
PPLPHARMA stock has fallen by −9.90% compared to the previous week, the month change is a −0.12% fall, over the last year PIRAMAL PHARMA LIMITED has showed a 94.73% increase.
We've gathered analysts' opinions on PIRAMAL PHARMA LIMITED future price: according to them, PPLPHARMA price has a max estimate of 310.00 INR and a min estimate of 260.00 INR. Watch PPLPHARMA chart and read a more detailed PIRAMAL PHARMA LIMITED stock forecast: see what analysts think of PIRAMAL PHARMA LIMITED and suggest that you do with its stocks.
PPLPHARMA reached its all-time high on Nov 6, 2024 with the price of 307.85 INR, and its all-time low was 61.65 INR and was reached on Mar 28, 2023. View more price dynamics on PPLPHARMA chart.
See other stocks reaching their highest and lowest prices.
PPLPHARMA stock is 2.47% volatile and has beta coefficient of −0.37. Track PIRAMAL PHARMA LIMITED stock price on the chart and check out the list of the most volatile stocks — is PIRAMAL PHARMA LIMITED there?
Today PIRAMAL PHARMA LIMITED has the market capitalization of ‪330.44 B‬, it has decreased by −4.85% over the last week.
Yes, you can track PIRAMAL PHARMA LIMITED financials in yearly and quarterly reports right on TradingView.
PIRAMAL PHARMA LIMITED is going to release the next earnings report on Jan 28, 2025. Keep track of upcoming events with our Earnings Calendar.
PIRAMAL PHARMA LIMITED revenue for the last quarter amounts to ‪22.42 B‬ INR, despite the estimated figure of ‪21.69 B‬ INR. In the next quarter, revenue is expected to reach ‪21.96 B‬ INR.
PPLPHARMA net income for the last quarter is ‪225.90 M‬ INR, while the quarter before that showed ‪−886.40 M‬ INR of net income which accounts for 125.49% change. Track more PIRAMAL PHARMA LIMITED financial stats to get the full picture.
Yes, PPLPHARMA dividends are paid annually. The last dividend per share was 0.11 INR. As of today, Dividend Yield (TTM)% is 0.04%. Tracking PIRAMAL PHARMA LIMITED dividends might help you take more informed decisions.
As of Dec 14, 2024, the company has ‪7.93 K‬ employees. See our rating of the largest employees — is PIRAMAL PHARMA LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PIRAMAL PHARMA LIMITED EBITDA is ‪13.44 B‬ INR, and current EBITDA margin is 15.42%. See more stats in PIRAMAL PHARMA LIMITED financial statements.
Like other stocks, PPLPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PIRAMAL PHARMA LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PIRAMAL PHARMA LIMITED technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PIRAMAL PHARMA LIMITED stock shows the buy signal. See more of PIRAMAL PHARMA LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.